drugset / Trial / NCT06783686

Evaluation of NV701 (Pilocarpine 1.25%) Compared With Vuity (Pilocarpine 1.25%) on Pupil Size in Subjects With Presbyopia

NCT06783686

Phase 0 Completed 55 enrolled Novus Vision LLC
RandomizedParallel-groupDouble-blindOther

Summary

Randomized contralateral eye study to evaluate the effect of one-time dosing of NV701 versus commercially available 1.25% pilocarpine solution on pupil size.

Timeline

Start
2025-01-30
Primary completion
2025-04-04
Completion
2025-05-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pilocarpine Unknown 1.25 % Topical

Indications